Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TMCI - Treace Medical Concepts Inc


IEX Last Trade
6.19
-0.080   -1.292%

Share volume: 346,431
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Surgical and Medical Instrument Manufacturing : -0.56%

PREVIOUS CLOSE
CHG
CHG%

$6.27
-0.08
-1.28%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
16%
Profitability 8%
Dept financing 21%
Liquidity 73%
Performance 9%
Company vs Stock growth
vs
Performance
5 Days
-3.89%
1 Month
-17.07%
3 Months
7.30%
6 Months
-54.36%
1 Year
-61.89%
2 Year
-68.28%
Key data
Stock price
$6.19
P/E Ratio 
-6.03
DAY RANGE
N/A - N/A
EPS 
-$1.03
52 WEEK RANGE
$3.92 - $15.98
52 WEEK CHANGE
-$0.60
MARKET CAP 
383.714 M
YIELD 
N/A
SHARES OUTSTANDING 
62.190 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.81
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$409,774
AVERAGE 30 VOLUME 
$831,520
Company detail
CEO: John T. Treace
Region: US
Website: treace.com
Employees: 371
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

treace medical concepts, inc. is a privately-funded, commercial stage company focused on bringing breakthrough technologies to the high-growth $1.1 billion us market for foot and ankle surgical products. we are committed to operating our business with the highest standards of ethical conduct. we will exceed our customers’ expectations through an innovation-driven, high-velocity approach to solving treatment and surgical problems. with our products and services, our mission is to assist foot and ankle physicians in improving patient outcomes and reducing healthcare costs, while providing a rewarding experience for our employees and an exceptional return for our shareholders.

Recent news